25.99MMarket Cap
LossP/E TTM
IGC Pharma Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of IGC Pharma Inc is 6.06, ranking 346 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is 39.09, which is 20.48% below the recent high of 47.10 and 119.24% above the recent low of -7.52.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.